• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转甲状腺素蛋白和视黄醇结合蛋白 4 基因人源化小鼠模型中的淀粉样沉积。

Amyloid deposition in a mouse model humanized at the transthyretin and retinol-binding protein 4 loci.

机构信息

Division of Respiratory Disease, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, China.

Department of Histology and Embryology, Harbin Medical University, Harbin, China.

出版信息

Lab Invest. 2018 Apr;98(4):512-524. doi: 10.1038/s41374-017-0019-y. Epub 2018 Jan 12.

DOI:10.1038/s41374-017-0019-y
PMID:29330472
Abstract

Familial amyloidotic polyneuropathy is an autosomal dominant disorder caused by a point mutation in the transthyretin (TTR) gene. The process of TTR amyloidogenesis begins with rate-limiting dissociation of the TTR tetramer. Thus, the TTR stabilizers, such as Tafamidis and Diflunisal, are now in clinical trials. Mouse models will be useful to testing the efficacy of these drugs. Although several mouse models have been generated, they all express mouse Rbp4. Thus, human TTR associates with mouse RBP4, resulting in different kinetic and thermodynamic stability profiles of TTR tetramers. To overcome this problem, we previously produced humanized mouse strains at both the TTR and Rbp4 loci (Ttr , Ttr , and Rbp4 ). By mating these mice, we produced double-humanized mouse strains, Ttr :Rbp4 and Ttr :Rbp4 . We used conventional transgenic mouse strains on a wild-type (Ttr :Tg[6.0hTTRMet30]) or knockout Ttr background (Ttr:Tg[6.0hTTRMet30]) as reference strains. The double-humanized mouse showed 1/25 of serum hTTR and 1/40 of serum hRBP4 levels. However, amyloid deposition was more pronounced in Ttr :Rbp4 than in conventional transgenic mouse strains. In addition, a similar amount of amyloid deposition was also observed in Ttr :Rbp4 mice that carried the wild-type human TTR gene. Furthermore, amyloid deposition was first observed in the sciatic nerve without any additional genetic change. In all strains, anti-TTR antibody-positive deposits were found in earlier age and at higher percentage than amyloid fibril deposition. In double-humanized mice, gel filtration analysis of serum revealed that most hTTR was free of hRBP4, suggesting importance of free TTR for amyloid deposition.

摘要

家族性淀粉样多发性神经病是一种常染色体显性疾病,由转甲状腺素蛋白(TTR)基因的点突变引起。TTR 淀粉样变性的过程始于 TTR 四聚体的限速解离。因此,TTR 稳定剂,如 Tafamidis 和 Diflunisal,目前正在临床试验中。小鼠模型将有助于测试这些药物的疗效。尽管已经产生了几种小鼠模型,但它们都表达小鼠 Rbp4。因此,人 TTR 与小鼠 Rbp4 结合,导致 TTR 四聚体的动力学和热力学稳定性谱不同。为了解决这个问题,我们之前在 TTR 和 Rbp4 基因座上产生了人源化小鼠品系(Ttr , Ttr , 和 Rbp4 )。通过交配这些小鼠,我们产生了双人类化小鼠品系,Ttr :Rbp4 和 Ttr :Rbp4 。我们使用传统的转基因小鼠品系作为野生型(Ttr :Tg[6.0hTTRMet30])或敲除 Ttr 背景(Ttr:Tg[6.0hTTRMet30])作为参考品系。双人类化小鼠的血清 hTTR 水平为 1/25,血清 hRBP4 水平为 1/40。然而,Ttr :Rbp4 中的淀粉样沉积比传统的转基因小鼠品系更为明显。此外,在携带野生型人 TTR 基因的 Ttr :Rbp4 小鼠中也观察到了类似数量的淀粉样沉积。此外,在没有任何其他遗传改变的情况下,首先在坐骨神经中观察到淀粉样沉积。在所有品系中,抗 TTR 抗体阳性沉积物的出现年龄较早,百分比高于淀粉样纤维沉积。在双人类化小鼠中,血清的凝胶过滤分析显示,大多数 hTTR 不含 hRBP4,这表明游离 TTR 对淀粉样沉积很重要。

相似文献

1
Amyloid deposition in a mouse model humanized at the transthyretin and retinol-binding protein 4 loci.转甲状腺素蛋白和视黄醇结合蛋白 4 基因人源化小鼠模型中的淀粉样沉积。
Lab Invest. 2018 Apr;98(4):512-524. doi: 10.1038/s41374-017-0019-y. Epub 2018 Jan 12.
2
CHF5074 (CSP-1103) stabilizes human transthyretin in mice humanized at the transthyretin and retinol-binding protein loci.CHF5074(CSP - 1103)可使在转甲状腺素蛋白和视黄醇结合蛋白基因座人源化的小鼠体内的人转甲状腺素蛋白保持稳定。
FEBS Lett. 2015 Mar 24;589(7):849-56. doi: 10.1016/j.febslet.2015.02.020. Epub 2015 Feb 26.
3
Analysis of amyloid deposition in a transgenic mouse model of homozygous familial amyloidotic polyneuropathy.纯合子家族性淀粉样多神经病转基因小鼠模型中淀粉样蛋白沉积的分析。
Am J Pathol. 1997 Apr;150(4):1497-508.
4
Identification of Transthyretin Tetramer Kinetic Stabilizers That Are Capable of Inhibiting the Retinol-Dependent Retinol Binding Protein 4-Transthyretin Interaction: Potential Novel Therapeutics for Macular Degeneration, Transthyretin Amyloidosis, and Their Common Age-Related Comorbidities.鉴定可抑制视黄醇依赖的视黄醇结合蛋白 4-转甲状腺素蛋白相互作用的转甲状腺素四聚体动力学稳定剂:用于治疗年龄相关性黄斑变性、转甲状腺素淀粉样变性及其共同的共病的潜在新型治疗药物。
J Med Chem. 2021 Jul 8;64(13):9010-9041. doi: 10.1021/acs.jmedchem.1c00099. Epub 2021 Jun 17.
5
Doxycycline disrupts transthyretin amyloid: evidence from studies in a FAP transgenic mice model.强力霉素破坏转甲状腺素蛋白淀粉样蛋白:来自家族性淀粉样多神经病转基因小鼠模型研究的证据。
FASEB J. 2006 Feb;20(2):234-9. doi: 10.1096/fj.05-4509com.
6
Discovery of Bispecific Antagonists of Retinol Binding Protein 4 That Stabilize Transthyretin Tetramers: Scaffolding Hopping, Optimization, and Preclinical Pharmacological Evaluation as a Potential Therapy for Two Common Age-Related Comorbidities.发现视黄醇结合蛋白 4 的双特异性拮抗剂,该拮抗剂稳定转甲状腺素蛋白四聚体:支架跳跃、优化和临床前药理学评价作为两种常见与年龄相关的共病的潜在治疗方法。
J Med Chem. 2020 Oct 8;63(19):11054-11084. doi: 10.1021/acs.jmedchem.0c00996. Epub 2020 Sep 17.
7
Evidence for early cytotoxic aggregates in transgenic mice for human transthyretin Leu55Pro.人转甲状腺素蛋白Leu55Pro转基因小鼠早期细胞毒性聚集体的证据。
Am J Pathol. 2002 Nov;161(5):1935-48. doi: 10.1016/S0002-9440(10)64469-0.
8
Comparison of amyloid deposition in two lines of transgenic mouse that model familial amyloidotic polyneuropathy, type I.I型家族性淀粉样多神经病转基因小鼠两条品系中淀粉样蛋白沉积的比较。
Transgenic Res. 1997 Jul;6(4):261-9. doi: 10.1023/a:1018454527309.
9
Amyloid and nonfibrillar deposits in mice transgenic for wild-type human transthyretin: a possible model for senile systemic amyloidosis.野生型人转甲状腺素蛋白转基因小鼠中的淀粉样和非纤维状沉积物:老年系统性淀粉样变性的一种可能模型。
Lab Invest. 2001 Mar;81(3):385-96. doi: 10.1038/labinvest.3780246.
10
TTR kinetic stabilizers and TTR gene silencing: a new era in therapy for familial amyloidotic polyneuropathies.转甲状腺素蛋白动力学稳定剂与转甲状腺素蛋白基因沉默:家族性淀粉样多发性神经病治疗的新时代。
Expert Opin Pharmacother. 2016;17(6):791-802. doi: 10.1517/14656566.2016.1145664. Epub 2016 Mar 10.

引用本文的文献

1
Mechanisms of damage and therapies for cardiac amyloidosis: a role for inflammation?心脏淀粉样变性的损伤机制与治疗:炎症起作用吗?
Clin Res Cardiol. 2024 Aug 21. doi: 10.1007/s00392-024-02522-2.
2
Dapagliflozin treatment and cardiovascular outcome in RBP4/TTR (transthyretin cardiac amyloidosis) mice.达格列净治疗 RBP4/TTR(转甲状腺素蛋白心脏淀粉样变性)小鼠的效果和心血管结局。
ESC Heart Fail. 2024 Feb;11(1):179-188. doi: 10.1002/ehf2.14567. Epub 2023 Oct 25.
3
High-avidity binding drives nucleation of amyloidogenic transthyretin monomer.
高亲和力结合驱动淀粉样变性转甲状腺素蛋白单体的成核。
JCI Insight. 2022 Apr 8;7(7):e150131. doi: 10.1172/jci.insight.150131.
4
Amyloid Formation by Globular Proteins: The Need to Narrow the Gap Between and Mechanisms.球状蛋白的淀粉样蛋白形成:缩小 与 机制之间差距的必要性。 (注:原文中“ 和 ”之间内容缺失,请补充完整以便更准确翻译)
Front Mol Biosci. 2022 Feb 14;9:830006. doi: 10.3389/fmolb.2022.830006. eCollection 2022.
5
Expression of Amyloidogenic Transthyretin Drives Hepatic Proteostasis Remodeling in an Induced Pluripotent Stem Cell Model of Systemic Amyloid Disease.淀粉样变转甲状腺素蛋白表达驱动系统性淀粉样变性疾病诱导多能干细胞模型中的肝蛋白质稳态重塑。
Stem Cell Reports. 2020 Aug 11;15(2):515-528. doi: 10.1016/j.stemcr.2020.07.003. Epub 2020 Jul 30.
6
Contributions of Animal Models to the Mechanisms and Therapies of Transthyretin Amyloidosis.动物模型对转甲状腺素蛋白淀粉样变性机制及治疗的贡献
Front Physiol. 2019 Apr 2;10:338. doi: 10.3389/fphys.2019.00338. eCollection 2019.